← Back to Search

Beta testing (CONNECTing to LungCare, feedback) for Smoking Cessation

N/A
Waitlist Available
Led By Judith Walsh-Cassidy, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >= 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This trial is testing a program called CONNECTing to LungCare, which aims to improve conversations between patients and healthcare providers about quitting smoking and getting screened for lung cancer. The program includes education and tools to

Who is the study for?
This trial is for individuals interested in quitting smoking and learning about lung cancer screening. Participants should be willing to engage in shared decision-making with their healthcare providers, using an educational intervention called CONNECTing to LungCare.Check my eligibility
What is being tested?
The study tests a program designed to help patients quit smoking and make informed decisions about lung cancer screening. It involves collecting saliva samples, completing surveys, and participating in the CONNECTing to LungCare education intervention.See study design
What are the potential side effects?
Since this trial focuses on education and counseling rather than medication or medical procedures, there are no direct side effects from interventions like drugs or surgery. However, participants may experience stress or anxiety related to discussions about smoking cessation and lung health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence rates
Number of eligible participants
Overall time required to recruit to the target sample size (Feasibility Cohort)
+2 more
Secondary outcome measures
Lung cancer screening (LCS) rates
Shared decision making about LCS
Smoking cessation rates

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Feasibility trial, Group I (CONNECTing to LungCare)Experimental Treatment3 Interventions
Participants receive the CONNECTing to LungCare intervention, including education about the benefits and risks of LCS and the importance of shared decision making, computerized assessments of the participant's smoking status, readiness to quit and concerns about quitting, and video segments tailored to the participant's responses to assessment questions, prior to their primary care appointment. Participants and their providers receive a tailored summary of the participant's concerns and barriers to quitting to enhance motivation for smoking cessation and shared decision-making discussions. Participants then receive up to 3 follow-up phone calls over 10-15 minutes each encouraging them to follow up with their provider, to complete the shared decision-making conversation, obtain LCS if appropriate, and access smoking cessation resources. Participants may also receive brief, tailored follow-up text messages that include links to video segments or cessation resources 1-3 times weekly.
Group II: Beta testing (CONNECTing to LungCare, feedback)Experimental Treatment2 Interventions
Participants interact with the CONNECTing to LungCare intervention and provide feedback in support of intervention refinement.
Group III: Feasibility trial, Group II (usual care)Active Control3 Interventions
Participants receive usual care from their provider at their primary care appointment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention
2005
N/A
~1800

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,501 Previous Clinical Trials
15,236,424 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,471 Total Patients Enrolled
Alere San DiegoIndustry Sponsor
9 Previous Clinical Trials
5,841 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being recruited for this ongoing medical study?

"Clinicaltrials.gov states that this particular trial is not currently seeking participants. It was originally posted on June 30, 2024, and the most recent update was made on January 9, 2024. However, there are currently numerous other trials available for enrollment with a total of 2638 active opportunities to participate."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
CONNECTing to LungCare
2024. "CONNECTing to LungCare". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06213532.
~98 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top